HRP20050110A2 - Novel salt and polymorphs of desloratadine hemifumarate - Google Patents

Novel salt and polymorphs of desloratadine hemifumarate

Info

Publication number
HRP20050110A2
HRP20050110A2 HR20050110A HRP20050110A HRP20050110A2 HR P20050110 A2 HRP20050110 A2 HR P20050110A2 HR 20050110 A HR20050110 A HR 20050110A HR P20050110 A HRP20050110 A HR P20050110A HR P20050110 A2 HRP20050110 A2 HR P20050110A2
Authority
HR
Croatia
Prior art keywords
desloratadine
temperature
stirring
polymorphic
dsc
Prior art date
Application number
HR20050110A
Other languages
English (en)
Croatian (hr)
Inventor
Kumar Ray Anup
Kumar V. Patel Hiren
R. Patel Mahendra
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HRP20050110A2 publication Critical patent/HRP20050110A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20050110A 2002-08-05 2003-07-17 Novel salt and polymorphs of desloratadine hemifumarate HRP20050110A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40115302P 2002-08-05 2002-08-05
PCT/US2003/022312 WO2004012738A1 (en) 2002-08-05 2003-07-17 Novel salt and polymorphs of desloratadine hemifumarate

Publications (1)

Publication Number Publication Date
HRP20050110A2 true HRP20050110A2 (en) 2006-02-28

Family

ID=31495932

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050110A HRP20050110A2 (en) 2002-08-05 2003-07-17 Novel salt and polymorphs of desloratadine hemifumarate

Country Status (17)

Country Link
US (1) US6962924B2 (no)
EP (1) EP1539161A1 (no)
JP (1) JP2005539010A (no)
KR (1) KR20050069976A (no)
CN (1) CN1674901A (no)
AU (1) AU2003251974C1 (no)
BR (1) BR0313231A (no)
CA (1) CA2494288A1 (no)
EC (1) ECSP055580A (no)
HR (1) HRP20050110A2 (no)
IL (1) IL166289A0 (no)
MX (1) MXPA05001470A (no)
NO (1) NO20051166L (no)
PL (1) PL374799A1 (no)
RU (1) RU2005106205A (no)
WO (1) WO2004012738A1 (no)
ZA (1) ZA200500372B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080461A2 (en) * 2003-03-12 2004-09-23 TEVA Gyógyszergyár Részvénytársaság Stable pharmaceutical compositions of desloratadine
SK50112007A3 (sk) * 2004-07-07 2007-07-06 Egis Gy�gyszergy�r Nyrt. Nový pseudopolymorf desloratadínu vytvorený s oxidom uhličitým
CA2541045A1 (en) * 2006-03-24 2007-09-24 Pharmascience Inc. A descarbonylethoxyloratadine containing pharmaceutical composition
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
CN110638750B (zh) * 2019-10-28 2021-08-27 深圳市贝美药业有限公司 一种地氯雷他定药物的制备方法及其制剂
CN113081958B (zh) * 2021-05-01 2022-05-03 安徽新世纪药业有限公司 一种地氯雷他定口服溶液及其制备方法
CN115785065A (zh) * 2022-12-02 2023-03-14 山东达因海洋生物制药股份有限公司 一种地氯雷他定共晶及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
WO1995025102A1 (en) * 1994-03-16 1995-09-21 Novo Nordisk A/S Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US6506767B1 (en) * 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
UA62976C2 (en) * 1997-07-02 2004-01-15 Schering Corp Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
US6335347B1 (en) 1997-10-10 2002-01-01 Schering Corporation Ethyl 4-(8-chloro-5,6-dihydro-11 H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidene carboxylate polymorph
EP1021436A1 (en) * 1997-10-10 2000-07-26 Schering Corporation ETHYL 4-(8-CHLORO-5, 6-DIHYDRO-11H- BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDIN -11-YLIDENE)-1- PIPERIDENE CARBOXYLATE POLYMORPH
US6100274A (en) 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
US20040058949A1 (en) 2004-03-25
ZA200500372B (en) 2006-07-26
AU2003251974A1 (en) 2004-02-23
AU2003251974C1 (en) 2006-09-14
NO20051166L (no) 2005-03-04
CA2494288A1 (en) 2004-02-12
CN1674901A (zh) 2005-09-28
RU2005106205A (ru) 2005-12-10
WO2004012738A1 (en) 2004-02-12
IL166289A0 (en) 2006-01-15
BR0313231A (pt) 2007-07-24
AU2003251974B2 (en) 2006-04-27
EP1539161A1 (en) 2005-06-15
US6962924B2 (en) 2005-11-08
PL374799A1 (en) 2005-10-31
MXPA05001470A (es) 2005-09-30
ECSP055580A (es) 2005-04-18
KR20050069976A (ko) 2005-07-05
JP2005539010A (ja) 2005-12-22

Similar Documents

Publication Publication Date Title
DE60207744D1 (de) Verfahren zur herstellung von 1,5,6,7-tetrahydropyrrolo[3,2-c]derivaten zur behandlung der fettleibigkeit
HRP20050110A2 (en) Novel salt and polymorphs of desloratadine hemifumarate
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
BRPI0111596B8 (pt) Composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto
HRP20030079B8 (hr) POSTUPAK PRIPRAVE NOVOG β-KRISTALNOG OBLIKA TERC-BUTILAMINSKE SOLI PERINDOPRILA
DK0835257T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser
EA200600372A1 (ru) Конденсированные с гетероарилом пиридины, пиразины и пиримидины в качестве лигандов рецептора кортикотропин-рилизинг-фактора (crf 1)
TR200102138T2 (tr) (S)-Omeprazolün potasyum tuzu.
Baumert et al. Development of small-molecule P-gp inhibitors of the N-benzyl 1, 4-dihydropyridine type: Novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties
Haas et al. The synthesis of pyridine derivatives from 3‐formylchromone
WO2002014281A8 (en) Pyridine derivatives as inhibitors of p38
BR9811658A (pt) Polimorfos de 8-cloro-6,11-dihidro-11-(4-piperidilideno)-5h-benzo [5,6]-ciclo hepta[1,2-b] piridina
Obydennov et al. A novel, two-step synthesis of 4-pyridone-3-carboxamides from 2-cyano-4-pyrones
KR100591935B1 (ko) Ｎｍｄａ-수용체 아형 차단제로서의 피리딘 유도체
JP2001500507A (ja) ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ピペリジニル化合物
KR890000706B1 (ko) 1,6-나프티리딘 유도체의 제조방법
CN101573113A (zh) 吡呤、中氮茚和喹嗪的衍生物、它们的制备和它们的治疗用途
RU2003118425A (ru) Новые соли деслоратадина, способ их получения и их содержащие фармацевтические композиции
PT1073438E (pt) Composicoes orais de 8-cloro-6,11-dihidro-11-(4-piperidilidina)-5h-benzo¬5,6|ciclohepta¬1,2-b|piridina
CA2398963A1 (en) New salt form and polymorphs
Brózda et al. Transformation of (+)-thiomicamine into a new ligand for the enantioselective addition of methyllithium to prochiral imines
US4560510A (en) Process and intermediates for the preparation of aryl substituted pyrido[1,4]benzodiazepines
Gudmundsson et al. An improved large scale synthesis of 2-amino-4-chloropyridine and its use for the convenient preparation of various polychlorinated 2-aminopyridines
Kaur et al. Synthesis of alkyl 6‐methyl‐4‐(2‐pyridyl)‐1, 2, 3, 4‐tetrahydro‐2H‐pyrimidine‐2‐one‐5‐carboxylates for evaluation as calcium channel antagonists
Nishiyama et al. Concise synthesis of azafluorenone and its application to indeno [1, 2-c] isoquinolone

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060626

Year of fee payment: 4

ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn